-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$6.00581.82% Upside
Carisma Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Carisma Therapeutics, Inc.?
Carisma Therapeutics, Inc. has been rated by research analysts at BTIG in the past 90 days.